Becker's Healthcare October 7, 2024
Alexandra Murphy

Novo Nordisk plans to invest approximately $158 million into revamping its Montes Claros manufacturing facility in Minas Gerais, Brazil, Bloomberg reported Oct. 5.

The plant is crucial for the company, producing 25% of its global insulin output. The modernization efforts aim to enhance production capabilities and incorporate sustainability projects that align with global environmental goals.

Since...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Trends
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
Researchers develop tool to measure biological age in individual cell types
NCPA to DOGE: Looking for Waste, Fraud, and Abuse? We Have Suggestions!
How 2 top Trump administration health leaders differ on Ozempic
The PBM Bill Failed. Americans Dodged A Bullet.

Share This Article